╨╧рб▒с>■  24■   1                                                                                                                                                                                                                                                                                                                                                                                                                                                ье┴` Ё┐ bjbj╦s╦s 4 йй       д▄▄▄▄▄▄▄дBBBB N║FvzzzzUUU┼╟╟╟╟╟╟$Vh╛Кы▄UUUUUы▄▄zz█╤╤╤UF▄z▄z┼╤U┼╤╤:═,▄▄ zj ░Ч<{ё ╔BЫ"∙ ┼0F H╜ H H▄ ╕UU╤UUUUUыы╟ UUUFUUUU║║║D■ D║║║■ Ё▄▄▄▄▄▄     CLINICAL PHARMACOLOGY (MSc/PgDip with a view to transfer to MSc/PgDip/PgCert) 57B200BT/61B200BT/61B200X5/62B200VZ Qualifications for entry: A degree or equivalent qualification, at the prescribed standard in Medicine, Pharmacology, Pharmacy or a relevant Science subject (e.g. Biochemistry, Biology, Biomedical Science). Duration: 12 months full-time or 24 months part-time (MSc); 9 months full-time (PgDip) Aim: To equip students for careers developing and expanding current knowledge of drugs. To achieve this the programme will provide a multi-disciplinary approach to the study of drug discovery and development; mechanisms of drug action; preclinical and clinical trials; and regulatory affairs. Content: The programme of taught courses will comprise lectures, tutorials, practical classes and demonstrations in clinical departments. The curriculum includes biochemical and molecular aspects of drug action; drug transport, metabolism and excretion; toxicology; pharmacokinetics; statistics; computing studies; industrial aspects of drug development; therapeutics; therapeutic drug monitoring; the influence of disease on drug handling; drug-drug interactions; the design and conduct of volunteer and clinical trials; monitoring drug safety. Candidates shall be required to attend the following designated programme of courses: First Half-Session GS 50M1 Generic Skills (0 credit points) MT 5003 Drug Metabolism and Toxicology (15 credit points) MT 5004 Therapeutics (10 credit points) MT 5006 Induction Course (5 credit points) MT 5008 Molecular Pharmacology (20 credit points) PU 5005 Applied Statistics (10 credit points) SK 5003 Information Skills (0 credit points) Second Half-Session MT 5501 Pharmacovigilance (5 credit points) MT 5502 Drug Development to Evidence Based Medicine (20 credit points) MT 5503 Pharmacokinetics (10 credit points) and one course chosen with the approval of the Head of the School from a list which will normally include the following: MT 5506 УOmicsФ in Research (5 credit points) MT 5701 Gene-nutrient Interactions (5 credit points) Diploma candidates may be allowed to transfer to the MSc if they complete the above programme at an appropriate standard. No candidate will be allowed to progress to the final stage as an MSc candidate if they fail to achieve an appropriate standard in the above programme. MSc candidates with a registered medical qualification may be able to carry out a clinical research project in the final stage under supervision of one of the medical staff. Final Stage MT 5801 Dissertation in Clinical Pharmacology (25 credit points) [Diploma candidates] MT 5802 Research Project in Clinical Pharmacology (80 credit points) [MSc candidates] Assessment: By practical work, by written essays and by oral presentations, or by a combination of these, as prescribed for each course. The project and dissertation will be assessed and there will usually be an oral examination on completion of the programme. Candidates must pass all courses at an appropriate standard for the award of the MSc degree. ЩP Z и й п ╤ ┌ O a жз\a  bc║╞ °я°я°ця°я°▌°▌°я°▌°я°я°╓ h hd!h >*OJQJh 5БOJQJh 6БOJQJh OJQJY~O P и й ╨ ╤ ў ° N O b c М ╞ ю Kєч█╬╛╬╬╬╬╬╛╬╬╬╬▒▒▒▒▒ ╞Д└d2 gd $ ╞0d2 a$gd ╞0d2 gd  ╞9r d2 gd  ╞D%┬dЁgd  ╞6$┬dЁgd  ¤Kyжз╗╝щ0\]╓;<■   ЄЄу╘┼ЄЄЄ▓▓ЄЄвХХХХ ╞0d2 gd $ ╞0d2 a$gd  ╞ 0*└ДШ■d2 `ДШ■gd  ╞ 0*└d2 gd  ╞ 0*└d2 gd  ╞ 0Д└d2 gd ╞Д└d2 gd  b╣║ Є▀╨├╛gd ╞0d2 gd  ╞ 9r 0d2 gd  ╞ 0ДДШ■d2 `ДШ■gd ╞Дd2 gd 21Рh:pАE▓░В. ░╞A!░ь"░#Ра$Ра%░░─░─ Р─ЖЬJ@ё J ╠^ЪNormal$a$CJOJQJ_HmH sH tH 8@8 ╠^Ъ Heading 2$@&>*>@> ╠^Ъ Heading 3$d8 @&5БPP [b┐ Heading 6 дЁд<@&5БCJOJQJ\БaJDAЄ бD Default Paragraph FontRiє │R  Table NormalЎ4╓ l4╓aЎ (kЇ ┴(No List4@Є4 TQHeader  ╞9r 0Uв0 [b┐ Hyperlink>*B*      !  "&г Y~OPий╨╤ў°NObcМ╞юKyжз╗╝щ0\]╓;<■   b ╣ ║  " Р$ффР$ффР$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$√■Р$ффY~OPий╨╤ў°NObcМ╞юKyжз╗╝щ0\]╓;<■   b ╣ ║  " (@0А2dА(@0А2dАШ@0А▐№АШ@0А▐№АШ@0А▐№АШ@0А▐№АШ@0А▐№АШ@0А▐№АШ@0А▐№АШ@0А▐№АШ@0А▐№АШ@0А▐№АШ@0А▐№АШ@0А▐№АШ@0А▐№АШ@0А▐№АШ@0А▐№АШ@0А▐№АШ@0А▐№АШ@0А▐№АШ@0А▐№АШ@0А▐№АШ@0А▐№А@0А2dАШ@0А,Ш@0А,Ш@0А,Ш@0А,Ш@0А,Ш@0А,Ш@0А,Ш@0А,Ш@0А,Ш@0А,Ш@0А,Ш@0А,Ш@0А,Ш@0А,Ш@0А,Ш@0А,Ш@0А,Ш0ААY~OPий╨╤ў°NObcМ╞юKyжз╗╝щ0\]╓;<■   b ╣ ║  " *@0АА*@0ААЪ@0ААЪ@0ААЪ@0ААЪ@0ААЪ@0ААЪ@0ААЪ@0ААЪ@0ААЪ@0ААЪ@0ААЪ@0ААЪ@0ААЪ@0ААЪ@0ААЪ@0ААЪ@0ААЪ@0ААЪ@0ААЪ@0ААЪ@0ААЪ@0АА@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0АААЪ@0ААЪ@0АААЪ@0АААЪ@0АААШ@0АААШ@0АААШ@0ААА 00с  K     Ё8Ё@ё   АААўЁТЁЁ0Ё( Ё ЁЁB ЁS Ё┐╦  ?Ё @Lбж┼╓сц" ]`" ::" " 1¤*└{         z√p>ыР         ДhДШ■╞h^Дh`ДШ■5o(.Р╩ ДкДШ■╞к^Дк`ДШ■ЗhИH.Т╩ ДzДL ╞z^Дz`ДL ЗhИH.Р╩ ДJ ДШ■╞J ^ДJ `ДШ■ЗhИH.Р╩ Д ДШ■╞ ^Д `ДШ■ЗhИH.Т╩ ДъДL ╞ъ^Дъ`ДL ЗhИH.Р╩ Д║ДШ■╞║^Д║`ДШ■ЗhИH.Р╩ ДКДШ■╞К^ДК`ДШ■ЗhИH.Т╩ ДZДL ╞Z^ДZ`ДL ЗhИH.╩ Д<ДШ■╞<^Д<`ДШ■o(ЗhИH.ДкДШ■╞к^Дк`ДШ■o(()Т╩ ДzДL ╞z^Дz`ДL ЗhИH.Р╩ ДJ ДШ■╞J ^ДJ `ДШ■ЗhИH.Р╩ Д ДШ■╞ ^Д `ДШ■ЗhИH.Т╩ ДъДL ╞ъ^Дъ`ДL ЗhИH.Р╩ Д║ДШ■╞║^Д║`ДШ■ЗhИH.Р╩ ДКДШ■╞К^ДК`ДШ■ЗhИH.Т╩ ДZДL ╞Z^ДZ`ДL ЗhИH.z√p1¤            (х'Dd  ╣Lм4d!B+Гx6─ 8П9╕k;Е@AKzE╤/LTQzVwX\Ёb`\NbZ gр$А┐FАAHЗ∙pКXС╠^ЪRЭ█QкАE▓[b┐е4┴#z╞╤Вwс╠$х)%ыA эМэ4Wї'Ў @А8L~ @@  Unknown            GРЗz А Times New Roman5РАSymbol3&Р Зz А ArialYР CG TimesTimes New Roman"qИЁ╨hN ╔&.╔F╧Q ╧Q !Ёьа┤┤ББ>4d   3ГqЁHX)Ё ?ф                     ╠^Ъ2  $ENERGY FUTURES (Nuclear) (MSc/PgDip)adr152adr152  ■ рЕЯЄ∙OhлС+'│┘0РРШ╚╘фЁ№ , L X dpxАИф(ENERGY FUTURES (Nuclear) (MSc/PgDip)adr152 Normal.dotadr1523Microsoft Office Word@F├#@6╛M ╔@М2xё ╔╧Q ■ ╒═╒Ь.УЧ+,∙о0  hpРШаи ░╕└╚ ╨ ф51cg и %ENERGY FUTURES (Nuclear) (MSc/PgDip) Title ■    ■   "#$%&'(■   *+,-./0■   ¤   3■   ■   ■                                                                                                                                                                                                                                                                                                           Root Entry         └F░аy{ё ╔5А1Table        \WordDocument        4 SummaryInformation(    !DocumentSummaryInformation8            )CompObj            q                        ■                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           ■       └FMicrosoft Office Word Document MSWordDocWord.Document.8Ї9▓q